Open Access Articles

Wendye M. DiSalvo
Margaret M. Joyce
Leslie B. Tyson
Ann E. Culkin
Kathleen Mackay
CJON 2008, 12(2), 341-352 DOI: 10.1188/08.CJON.341-352
Despite the common occurrence of cancer-related dyspnea, a paucity of literature is available for review, especially research literature that reports interventions to control dyspnea. The Oncology Nursing Society's Putting Evidence Into Practice® (PEP) initiative organized a team on nurses to...
0
No votes yet
Christine Miaskowski
Lillie Shockney
Rowan T. Chlebowski
CJON 2008, 12(2), 213-221 DOI: 10.1188/08.CJON.213-221
Many factors contribute to the success or failure of adjuvant therapy, but perhaps one of the most critical is treatment adherence. Patients do not adhere to prescribed therapy for a variety of reasons, and each one should be uncovered and addressed or managed accordingly to maintain therapeutic...
0
No votes yet
Clara Granda-Cameron
Sara R. Viola
Mary Pat Lynch
Rosemary C. Polomano
CJON 2008, 12(1), 65-77 DOI: 10.1188/08.CJON.65-77
Outcomes measurement is necessary to evaluate quality of care, increase knowledge about experiences with cancer and therapies, and determine the effectiveness of interventions directed toward improving symptoms and quality of life (QOL) in research and clinical care. Recent attention on outcomes...
0
No votes yet
Editorial
Open Access Article
CJON 2008, 12(1), 17-18 DOI: 10.1188/08.CJON.17-18
The following oncology nurses compose the Editorial Board of the Clinical Journal of Oncology Nursing (CJON) in 2008. They all are involved in clinical care and support the mission of CJON , which is to provide practical information necessary to care for patients and their families across the...
0
No votes yet
Open Access Article
Evidence-Based Practice
Caryl D. Fulcher
Terry Badger
Ashley K. Gunter
Joyce A. Marrs
Jill M. Reese
CJON 2008, 12(1), 131-140 DOI: 10.1188/08.CJON.131-140
Download the 2014 revision to Putting Evidence Into Practice interventions for depression for free at https://cjon.ons.org/file/13986/download by Fulcher et al., CJON, 18 (6, Suppl.), 26-37. Depression and depressive symptoms are prevalent in people with cancer, yet interventions for depression are...
0
No votes yet
CJON 2008, 12(1), 19 DOI:
The Clinical Journal of Oncology Nursing (CJON) offers an opportunity each year for novice writers to work with experienced authors who will mentor them through the writing and publishing process. In 2007, seven direct caregivers were paired with mentors, who have guided them through the manuscript...
0
No votes yet
Debra J. Harris
June Eilers
Amber Harriman
Barbara J. Cashavelly
Cathy Maxwell
CJON 2008, 12(1), 141-152 DOI: 10.1188/08.CJON.141-152
Download the 2014 revision to Putting Evidence Into Practice interventions for oral mucositis for free at https://cjon.ons.org/file/14006/download by Eilers et al., CJON, 18 (6, Suppl.), 80-96. Mucositis, an inflammation of the mucous membranes, is a commonly occurring side effect of chemotherapy...
0
No votes yet
Page Bertolotti
Elizabeth Bilotti
Kathleen Colson
Kathleen Curran
Deborah Doss
Beth Faiman
Maria Gavino
Bonnie Jenkins
Kathy Lilleby
Ginger Love
Patricia A. Mangan
Emily McCullagh
Teresa Miceli
Kena Miller
Kathryn Rogers
Sandra Rome
Stacey Sandifer
Lisa C. Smith
Joseph D. Tariman
Jeanne Westphal
CJON 2008, 12(3), 9-12 DOI: 10.1188/08.CJON.S1.9-12
Nurses play an essential role in managing the care of patients with multiple myeloma, who require education and support to receive and adhere to optimal therapy. The International Myeloma Foundation created a Nurse Leadership Board comprised of oncology nurses from leading cancer centers and...
0
No votes yet
Joseph D. Tariman
Ginger Love
Emily McCullagh
Stacey Sandifer
CJON 2008, 12(3), 29-35 DOI: 10.1188/08.CJON.S1.29-35
The novel therapies thalidomide and bortezomib can cause peripheral neuropathy, a challenging adverse event that can affect quality of life and compromise optimal treatment for patients with multiple myeloma. At baseline, patients should be evaluated for signs and symptoms of peripheral neuropathy...
0
No votes yet
Sandra Rome
Deborah Doss
Kena Miller
Jeanne Westphal
CJON 2008, 12(3), 21-28 DOI: 10.1188/08.CJON.S1.21-27
Patients with myeloma are at risk for serious and life-threatening thromboembolic events because of their disease, individual risk factors, and antimyeloma or other medications. The International Myeloma Foundation's Nurse Leadership Board developed this consensus statement for assessment and...
0
No votes yet